Subscribe to the Pharma Marketing News Feed. Access article summaries and order reprints automatically via your RSS reader (e.g., RSSReader). No e-mail hassles, no sign-up necessary.
	Stay current with Pharma Marketing News on your personal My Yahoo! page.

Whither Twitter for Pharma?

Twitter is growing by leaps and bounds! According to comScore Media Metrix data, there were 17 million U.S. visitors to Twitter.com during April, 2009. This represents an 83% gain vs. March and a 3,000% gain vs. year ago. Neilsen, on the other hand, estimates there was a 1,448 percent increase between May 2008 and May 2009. All this makes Twitter attractive to pharmaceutical marketers. But can pharma's Twitter campaigns reach a significant number of people? Will they reach the right people? Is Twitter even appropriate for branded messages? Read the full text of this OpEd piece...

Pharma Marketers Dive Deeper Into Social Media: The Good, the Bad, & the Ugly Case Studies

This article focuses in some detail on three interesting pharma social media initiatives: (1) Procter & Gamble's Asacol Community for Ulcerative Colitis Patients; (2) Novo Nordisk's Levemir-branded Race With Insulin Twitter account; and (3) UCB's sponsored epilepsy community on the PatientsLikeMe website. Read more... and purchase the reprint without subscribing.

How Should Pharma Engage in Social Networks?: Thoughts on Best Practices

Each pharmaceutical company should have its own guidelines for best practices in the social media space. To assist in that discussion, Pharma Marketing News hosted a survey to explores issue relating to pharma advertising and engagement in social networks. This article summarizes the results of that survey. Read more... and purchase the reprint without subscribing.

FDA Draft Guidance on Risk Communication: Reading the Tea Leaves

The recent FDA Draft Guidance for Industry, Presenting Risk Information in Prescription Drug and Medical Device Promotion guidance focuses almost exclusively on print and broadcast promotional ads. It is possible, however, to apply some of FDA's "thinking" to certain kinds of Internet ads such as search engine paid ads. Read more... and purchase the reprint without subscribing.